Pembina Pipeline Corporation (NYSE:PBA) shares decreased -4.41% in last trading session and ended the day at $19.73. Pembina Pipeline Corporation (NYSE:PBA) quarterly performance is -27.89%.
Pembina Pipeline (NYSE: PBA) declared a quarterly dividend of $0.1525 per share, or $0.61 annualized. The dividend will be payable on February 15, 2016, to stockholders of record on January 25, 2016, with an ex-dividend date of January 21, 2016.
Winthrop Realty Trust (NYSE:FUR) ended the last trading day at $12.96. Company weekly volatility is calculated as 1.15% and price to cash ratio as 8.32. Winthrop Realty Trust (NYSE:FUR) showed a weekly performance of -0.84%.
On 4 January, Winthrop Realty Trust (NYSE:FUR) announced that the report in the San Antonio Business Journal that Winthrop has acquired a multi-family property in San Antonio, Texas is incorrect. As previously reported, Winthrop has adopted a plan of liquidation and is not seeking to acquire any additional assets. The report in the San Antonio Business Journal has since been withdrawn.
On 07 January, Qorvo, Inc. (NASDAQ:QRVO) shares increased 2.29% and was closed at $45.64. QRVO EPS growth in last 5 year was 16.10%. Qorvo, Inc. (NASDAQ:QRVO) year to date (YTD) performance is -10.33%.
Qorvo® (NASDAQ: QRVO) announced it expects revenue and earnings for its fiscal 2016 third quarter will be lower than it previously estimated on November 5, 2015. Qorvo currently expects its December quarterly revenue will be approximately $620 million, versus its original guidance of $720-$730 million provided November 5, 2015 in its second quarter earnings report. The revenue decline is the result of weaker than forecasted customer demand in the Company’s Mobile Products segment. Operating expenses are expected to decline sequentially, reflecting a significant reduction in variable compensation expense.
Cesca Therapeutics Inc. (NASDAQ:KOOL) shares decreased -6.96% in last trading session and ended the day at $0.16. KOOL Gross Margin is 25.70% and its has a return on assets of -42.80%. Cesca Therapeutics Inc. (NASDAQ:KOOL) quarterly performance is -72.54%.
Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company announced that the Company will present at the Biotech Showcase™ 2016 on Wednesday, January 13th at 11:30 AM PT (2:30 PM ET).
Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) caters to the Healthcare space. Its weekly performance is -11.51%. On the last day of trading company shares ended up at $2.46. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) distance from 50-day simple moving average (SMA50) is -23.85%.
Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) announced that the three-month, double-blind, placebo-controlled stage of the company’s multicenter Phase 2 Liver Cirrhosis clinical trial showed a statistically significant reduction in caspase-cleaved cytokeratin 18 (cCK18) vs. placebo (p=0.04) in the overall patient population when adjusted for differences between treatment and placebo groups in baseline Model for End-stage Liver Disease (MELD)1 score and disease etiology as specified in the trial statistical analysis plan. cCK18 is a mechanism-specific biomarker of caspase-driven cell death.
Leave a Reply